Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | 126.68 |
peg ratio | 1.40 |
price to book ratio | 61.89 |
price to sales ratio | 20.81 |
enterprise value multiple | -2.34 |
price fair value | 61.89 |
profitability ratios | |
---|---|
gross profit margin | -177.37% |
operating profit margin | -895.47% |
pretax profit margin | -1179.67% |
net profit margin | 969.49% |
return on assets | 44.42% |
return on equity | 92.06% |
return on capital employed | -44.25% |
liquidity ratio | |
---|---|
current ratio | 4.59 |
quick ratio | 4.59 |
cash ratio | 3.77 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 338.18 |
days of payables outstanding | 76.90 |
cash conversion cycle | 261.28 |
receivables turnover | 1.08 |
payables turnover | 4.75 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.00 |
debt equity ratio | 0.00 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.00 |
interest coverage | -479.22 |
cash flow to debt ratio | -136.44 |
cash flow ratios | |
---|---|
free cash flow per share | -0.06 |
cash per share | 0.03 |
operating cash flow per share | -0.06 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -136.44 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -2,409.91 |
Frequently Asked Questions
Addex Therapeutics Ltd (ADXN) published its most recent earnings results on 22-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Addex Therapeutics Ltd (NASDAQ:ADXN)'s trailing twelve months ROE is 92.06%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Addex Therapeutics Ltd (ADXN) currently has a ROA of 44.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ADXN reported a profit margin of 969.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.59 in the most recent quarter. The quick ratio stood at 4.59, with a Debt/Eq ratio of 0.00.